Skip to main content
  • Log in

Dundee Research Interest Group

Dealing with Parkinson's Research

Main navigation

  • Home
  • About
    • About Us
    • DRIG Business
    • Glossary
  • News
  • Events
    • Upcoming Events
    • Past Events
    • Lab Visit Reports
  • Patients
    • My Parkinson's
    • Parky Poetry
  • Research
    • Research In Depth
    • Trials
  • Contact

Main navigation

  • Home
  • About
    • About Us
    • DRIG Business
    • Glossary
  • News
  • Events
    • Upcoming Events
    • Past Events
    • Lab Visit Reports
  • Patients
    • My Parkinson's
    • Parky Poetry
  • Research
    • Research In Depth
    • Trials
  • Contact

Event | Parkinson's and Technology, a series of 3 Meetings - Part 3

Parkinsons UK Logo

Key Facts

Date:
Saturday, March 27, 2021 - 14:00
Venue:
Zoom
Speakers:
● Professor Richard Walker Richard is a Consultant and previous Director of R&D at North Tyneside General Hospital, and Honorary Professor of Ageing and International Health at Newcastle University.
● Dr Athanasios Tsanas ('Thanasis'), BSc, BEng, MSc, DPhil (Oxon), SMIEEE, FHEA, FRSM Thanasis studied Engineering and completed a DPhil (PhD) in Applied Mathematics at the University of Oxford (2012).
● Dr Rutger Zietsma Rutger is founding CEO of Edinburgh-based Manus Neurodynamica Ltd – the company that created the NeuroMotor PenTM (NMP).
● Professor Tiago Guerreiro Tiago is a Professor of Computer Science at Faculdade de Ciências da Universidade de Lisboa and a researcher at LASIGE

The Road towards Optimal Treatment

Introduction

The two previous events have focused mainly on ways to give the patient more control and influence over symptoms and their effects. In both cases, continuous and objective measurement is the basis for action.

However, the data obtained are also a source of information that can be made available to the treating physician. Since they are determined over a longer period of time, they do not only reflect a random current status but also the development of the condition. This means that the consultation, which takes place every six months or a year, is based on a comprehensive basis of confirmed data and replaces the 'snapshot diagnosis', which requires a very experienced doctor to recognise misleading or day-dependent factors as such and eliminate them.

In addition, the use of intelligent solutions allows the detection of critical developments and early or timely intervention. This raises the question of how much responsibility the patient is willing to hand over to the monitoring system and when the doctor's responsibility begins. This question will certainly be discussed at length and controversially; ultimately, each patient must answer it for himself.

But we can certainly draw one conclusion: intelligent solutions have the potential to support and guide the doctor in determining the optimal treatment. We are only just beginning to glimpse their potential.

And that's the good news: Parkinson's, we'll get you!

Attendance at this event is free of charge, but reservations are required:

 

 

Event Gallery

Helpline

0808 800 0303

The Parkinson’s UK helpline is a free and confidential service providing support to anyone affected by Parkinson’s.

hello@parkinsons.org.uk
Emails answered within 5 working days.

Text relay: 18001 0808 800 0303
Textphone number for textphone users only.

Support for you

  • Worried you have Parkinson's?
  • Carer or family member?
  • Find local support
  • Health or social care professionals
  • Living with Parkinson's
  • Recently diagnosed?

Follow us

  • Facebook
  • Twitter
  • YouTube
  • Instagram
  • Email

Parkinson's UK

Parkinson's UK
215 Vauxhall Bridge Road
London
SW1V 1EJ

Tel: 020 7931 8080

Parkinson's UK is the operating name of the Parkinson's Disease Society of the United Kingdom. 

A registered charity in England and Wales (258197) and in Scotland (SC037554).

Privacy Policy
Web Design by Matthew Elliott
2020 © Dundee Research Interest Group